<i>Bifidobacterium longum</i> and Galactooligosaccharide Improve Skin Barrier Dysfunction and Atopic Dermatitis-like Skin
Sukyung Kim, Song-Yi Han, Jin-Young Lee, Narae Kim, Bora Lee, Hyunmi Kim, Mijeoung Kwon, Kangmo Ahn, Youngbae Noh, Sang Jong Kim, Phyrim Lee, Dongki Kim, Byung Eui Kim, Jihyun Kim
Abstract
PURPOSE: and galactooligosaccharide (GOS) for the treatment of atopic dermatitis (AD) have not been elucidated. METHODS: abundance were evaluated in mice. RESULTS: alone. CONCLUSIONS: and GOS improve DNCB-induced skin barrier dysfunction and AD-like skin.
Topics & Concepts
Bifidobacterium longumAtopic dermatitisTransepidermal water lossImmunologyImmunoglobulin EImiquimodMedicineBifidobacteriumChemistryAntibodyPathologyLactobacillusFood scienceFermentationStratum corneumDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases